Dec 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Citigroup, Salesforce and Zscaler, on Tuesday.
HIGHLIGHTS
* Citigroup C.N: KBW raises to outperform from market perform |
* PTC Therapeutics Inc PTCT.O: RBC raises to outperform from sector perform |
* Salesforce Inc CRM.N: D.A. Davidson raises target price to $300 from $250 |
* State Street Corp STT.N: KBW raises to outperform from market perform |
* Zscaler Inc ZS.O: Piper Sandler raises target price to $235 from $215 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Ares Management Corp ARES.N: CFRA raises target price by $15 to $205 |
* Citigroup C.N: KBW raises target price to $82 from $70 |
* Citigroup C.N: KBW raises to outperform from market perform |
* Fedex Corp FDX.N: JP Morgan raises target price to $366 from $350 |
* GE Vernova Inc GEV.N: JP Morgan raises target price to $356 from $330 |
* Hologic Inc HOLX.O: Stephens cuts target price to $90 from $95 |
* Lemonade Inc LMND.N: Jefferies raises target price to $20 from $17 |
* Ligand Pharmaceuticals Inc LGND.O: RBC raises target price to $141 from $140 |
* PTC Therapeutics Inc PTCT.O: Jefferies raises target price to $62 from $55 |
* PTC Therapeutics Inc PTCT.O: JP Morgan raises target price to $74 from $62 |
* PTC Therapeutics Inc PTCT.O: Leerink Partners raises target price to $50 from $40 |
* PTC Therapeutics Inc PTCT.O: RBC raises target price to $63 from $39 |
* PTC Therapeutics Inc PTCT.O: RBC raises to outperform from sector perform |
* Revolution Medicines Inc RVMD.O: JP Morgan raises target price to $71 from $63 |
* Salesforce Inc CRM.N: D.A. Davidson raises target price to $300 from $250 |
* State Street Corp STT.N: KBW raises target price to $120 from $105 |
* State Street Corp STT.N: KBW raises to outperform from market perform |
* Zscaler Inc ZS.O: Piper Sandler raises target price to $235 from $215 |
* Zscaler Inc ZS.O: Scotiabank raises target price to $205 from $195 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。